Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung Cancer

Background: Anlotinib is a novel anti-angiogenesis drug. In non-small cell lung cancer (NSCLC), high body mass index (BMI) was not associated with worse survival in patients treated with bevacizumab compared with those with normal or low BMI. However, it remains unknown whether such an association s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Anning Xiong (Egilea), Wei Nie (Egilea), Lei Cheng (Egilea), Hua Zhong (Egilea), Tianqing Chu (Egilea), Runbo Zhong (Egilea), Jun Lu (Egilea), Shuyuan Wang (Egilea), Jianlin Xu (Egilea), Yinchen Shen (Egilea), Feng Pan (Egilea), Baohui Han (Egilea), Xueyan Zhang (Egilea)
Formatua: Liburua
Argitaratua: Frontiers Media S.A., 2022-03-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri